Feature Article | Former Athira CEO returns to Seattle biotech scene with Kirkland company
Sep 2
1 min read
Leen Kawas is back in an operating seat. This piece covers her return to running a company as CEO of EIT Pharma after several years focused on investing through Propel Bio Partners, the venture firm she co-founded with early Athira backer Richard Kayne, and what the move means for EIT's growth in Seattle.
Comments